|
12.2.1 Drugs used in nasal allergy |
||
|
Azelastine nasal spray 140mcg/m.i |
R |
ENT |
|
Beclometasone (Beclomethasone) nasal spray, aqueous |
R |
ENT |
|
Fluticasone nasal spray 50mcg/m.i |
R |
ENT |
|
Mometasone nasal spray 50mcg/m.i |
R |
ENT |
|
12.2.2 Topical nasal decongestants |
||
|
Ephedrine nasal drops 0.5%, 1% |
F |
|
|
Xylometazoline nasal drops 0.05%, 0.1% |
F |
|
Treatment periods should be restricted to less than seven days to avoid rebound congestion.
|
12.2.3 Anti-infective nasal preparations |
||
|
Mupirocin nasal ointment 2% |
R |
Microbiology approval (MRSA) |
|
Naseptin nasal cream |
F |
|